The article "Acute Kidney Disease and Renal Recovery: Consensus Report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup" provides a comprehensive overview of the current understanding and management of acute kidney injury (AKI) and acute kidney disease (AKD). The authors, representing a diverse panel of clinicians and researchers, define AKD as a condition where criteria for AKI stage 1 or greater persist for ≥7 days after an AKI initiating event. They propose a staging system for AKD and emphasize the importance of early identification and management of persistent AKI to prevent further kidney damage and improve outcomes. Key points include: - **Definition and Staging**: AKD is defined as a condition where AKI stage 1 or greater persists for ≥7 days, with a staging system provided. - **Management**: Recommendations for initial management of persistent AKI, including reassessment of underlying causes and precise measurement of kidney function. - **Follow-up Care**: A 'layered' approach to follow-up care is suggested, with the intensity of care increasing based on the risk of intermediate and long-term outcomes. - **Renal Replacement Therapy (RRT)**: Guidelines for assessing recovery from RRT dependence are provided, emphasizing sustained independence from RRT for at least 14 days. - **Research Recommendations**: The article highlights the need for further research to develop tools for identifying patients at risk of persistent AKI, assessing renal function, and understanding the natural history of AKD. The consensus statement aims to standardize approaches and enable comparisons in future studies, ultimately improving patient outcomes and care for those affected by AKD.The article "Acute Kidney Disease and Renal Recovery: Consensus Report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup" provides a comprehensive overview of the current understanding and management of acute kidney injury (AKI) and acute kidney disease (AKD). The authors, representing a diverse panel of clinicians and researchers, define AKD as a condition where criteria for AKI stage 1 or greater persist for ≥7 days after an AKI initiating event. They propose a staging system for AKD and emphasize the importance of early identification and management of persistent AKI to prevent further kidney damage and improve outcomes. Key points include: - **Definition and Staging**: AKD is defined as a condition where AKI stage 1 or greater persists for ≥7 days, with a staging system provided. - **Management**: Recommendations for initial management of persistent AKI, including reassessment of underlying causes and precise measurement of kidney function. - **Follow-up Care**: A 'layered' approach to follow-up care is suggested, with the intensity of care increasing based on the risk of intermediate and long-term outcomes. - **Renal Replacement Therapy (RRT)**: Guidelines for assessing recovery from RRT dependence are provided, emphasizing sustained independence from RRT for at least 14 days. - **Research Recommendations**: The article highlights the need for further research to develop tools for identifying patients at risk of persistent AKI, assessing renal function, and understanding the natural history of AKD. The consensus statement aims to standardize approaches and enable comparisons in future studies, ultimately improving patient outcomes and care for those affected by AKD.